# Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy

> **NCT06268418** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 46 (actual)

## Conditions studied

- Radionucleide Therapy

## Interventions

- **OTHER:** Artificial intelligence

## Key facts

- **NCT ID:** NCT06268418
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-30
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06268418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06268418, "Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06268418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*